Clover Health Investments (CLOV) Cash & Current Investments (2019 - 2026)

Clover Health Investments' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $197.5 million for Q1 2026.

• Quarterly Cash & Current Investments rose 23.34% year-over-year to $197.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.5 million (up 23.34% YoY) and the FY2025 annual result came in at $95.3 million, down 56.96% from the prior year.
• Cash & Current Investments was $197.5 million for Q1 2026 at Clover Health Investments, up from $95.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $492.7 million in Q2 2023 and bottomed at $95.3 million in Q4 2025.
• A 5-year average of $274.0 million and a median of $264.4 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments soared 45.24% — and 2025, when it slumped 56.96%.
• Clover Health Investments' Cash & Current Investments stood at $293.3 million in 2022, then retreated by 23.77% to $223.6 million in 2023, then dropped by 0.91% to $221.5 million in 2024, then slumped by 56.96% to $95.3 million in 2025, then soared by 107.09% to $197.5 million in 2026.
• Business Quant data shows CLOV's Cash & Current Investments at $197.5 million in Q1 2026, $95.3 million in Q4 2025, and $201.0 million in Q3 2025.